Funded Tech Companies

Vaderis Therapeutics

Based in Basel, Vaderis Therapeutics has funding from Omega Funds, Droia Ventures and Medicxi Ventures.

Company Overview

Contact Information

Company Background Information

Overview

Vaderis is a science-driven, patient-focused biotech with a singular aim: to be the first to bring breakthrough therapies to people with HHT and other rare vascular diseases. Our work is guided by deep biological insight, a relentless commitment to rigorous science, impeccable execution and an unwavering belief that meaningful change is possible. We advance with purpose, inspired by the patients who drive us forward and by the promise of what has yet to be achieved. Pioneering care for people with unmet needs.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/11/2026

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Azmi Nabulsi

        

Chief Medical Officer

Damien Picard

        

Chief Medical Officer

Darryl Sleep

        

Chief Operating Officer

Tom Harris

        

Chief Operating Officer

Karen Zylberman

        

Chief Scientific Officer

Pierre Saint-Mezard

        

VP - Human Resources

Moon Kim

        

VP - Operations

Maria Buckley

        

Company Investors

• Omega Funds
• Droia Ventures
• Medicxi Ventures
• TCGX
• EQT Life Sciences
• Perceptive Advisors
• Goldman Sachs

Browse more funded tech companies:

Vade Secure | Vadio

Share this article

About Our VC & M&A Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary